Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Operating Expenses | 220 | 272 | 192 | 0 | 0 |
| Operating Income | -220 | -272 | -192 | N/A | N/A |
| Other Income | 283 | 274 | 212 | 0 | 0 |
| Pre-tax Income | 63 | 2 | 20 | 0 | 0 |
| Income Tax | 35 | 9 | 4 | N/A | N/A |
| Net Income Continuous | 28 | -7 | 16 | N/A | N/A |
| Net Income | $28 | $-7 | $16 | $N/A | $N/A |
| EPS Basic Total Ops | -0.60 | -0.60 | -0.70 | N/A | N/A |
| EPS Basic Continuous Ops | 0.11 | -0.03 | 0.06 | N/A | N/A |
| EPS Diluted Total Ops | -0.60 | -0.60 | -0.70 | N/A | N/A |
| EPS Diluted Continuous Ops | 0.11 | -0.03 | 0.06 | N/A | N/A |
| EBITDA(a) | $-220 | $-272 | $-192 | $N/A | $N/A |